Rhinal Therapeutics Inc.

New Filing
CIK: 0002080382·Biotechnology·NEVADA·Filed: Aug 7, 2025
Total Offering

$1,000,000

Amount Sold

$20,000

Investors

1

First Sale

Jul 28, 2025

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2023
Non-Accredited Investors
No

Related Persons

NameRole
Lawrence Fox
Related Person
Frank Puglisi
Related Person
Austin Panhans
Related Person
Robert Clayborough
Related Person
Mike George
Related Person

Company

Rhinal Therapeutics Inc.

732 S 6TH ST

LAS VEGAS, NV, 89101

7029816980

SEC Filing

0002080382-25-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Rhinal Therapeutics Inc. Form D Filing — $1,000,000 | FilingFlow